Literature DB >> 30897069

PATIENTS PRESENTING EMERGENTLY WITH PROLIFERATIVE DIABETIC RETINOPATHY: Follow-up and Factors Associated With Compliance.

John W Hinkle1, Harry W Flynn, James T Banta, Elizabeth A Vanner.   

Abstract

PURPOSE: To determine the rate of follow-up after emergent encounters for proliferative diabetic retinopathy and to identify patient or visit characteristics associated with follow-up compliance.
METHODS: A retrospective cohort study of patients presenting to an ophthalmic emergency department with active proliferative diabetic retinopathy between May 2014 and December 2016 was conducted. Demographic data and encounter data were gathered for each emergency department visit. Compliance with follow-up was defined as a completed clinic visit as scheduled after the emergency encounter.
RESULTS: A total of 590 emergency department encounters were included. The overall follow-up rate was 61.9%. Married patients and those with Public Health Trust insurance had increased odds of compliance (odds ratio [OR]: 1.507, P = 0.04; OR: 2.749, P < 0.0001). Patients with Medicaid had reduced odds (OR: 0.543, P = 0.004). Patients with longer emergency department encounters and longer intervals to follow-up had reduced odds (OR: 0.948, P = 0.001; OR of 0.941, P < 0.0001). The other characteristics were not significantly associated with follow-up compliance.
CONCLUSION: Patients who present emergently with active proliferative diabetic retinopathy are at high risk of following up noncompliance. Characteristics with significant effects on the odds of follow-up compliance include specific insurance payer, marriage status, length of visit, and interval to follow-up.

Entities:  

Mesh:

Year:  2020        PMID: 30897069      PMCID: PMC6739198          DOI: 10.1097/IAE.0000000000002481

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   3.975


  23 in total

1.  Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Authors:  Jeffrey G Gross; Adam R Glassman; Lee M Jampol; Seidu Inusah; Lloyd Paul Aiello; Andrew N Antoszyk; Carl W Baker; Brian B Berger; Neil M Bressler; David Browning; Michael J Elman; Frederick L Ferris; Scott M Friedman; Dennis M Marcus; Michele Melia; Cynthia R Stockdale; Jennifer K Sun; Roy W Beck
Journal:  JAMA       Date:  2015-11-24       Impact factor: 56.272

2.  Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1976-04       Impact factor: 5.258

3.  Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Int Ophthalmol Clin       Date:  1987

Review 4.  When to use the Bonferroni correction.

Authors:  Richard A Armstrong
Journal:  Ophthalmic Physiol Opt       Date:  2014-04-02       Impact factor: 3.117

5.  Injury type and emergency department management of orthopaedic patients influences follow-up rates.

Authors:  Michelle M Coleman; Laura N Medford-Davis; Omar H Atassi; Angela Siler-Fisher; Charles A Reitman
Journal:  J Bone Joint Surg Am       Date:  2014-10-01       Impact factor: 5.284

6.  Large Disparities in Receipt of Glaucoma Care between Enrollees in Medicaid and Those with Commercial Health Insurance.

Authors:  Angela R Elam; Chris Andrews; David C Musch; Paul P Lee; Joshua D Stein
Journal:  Ophthalmology       Date:  2017-06-02       Impact factor: 12.079

7.  US Spending on Personal Health Care and Public Health, 1996-2013.

Authors:  Joseph L Dieleman; Ranju Baral; Maxwell Birger; Anthony L Bui; Anne Bulchis; Abigail Chapin; Hannah Hamavid; Cody Horst; Elizabeth K Johnson; Jonathan Joseph; Rouselle Lavado; Liya Lomsadze; Alex Reynolds; Ellen Squires; Madeline Campbell; Brendan DeCenso; Daniel Dicker; Abraham D Flaxman; Rose Gabert; Tina Highfill; Mohsen Naghavi; Noelle Nightingale; Tara Templin; Martin I Tobias; Theo Vos; Christopher J L Murray
Journal:  JAMA       Date:  2016-12-27       Impact factor: 56.272

8.  Vision health disparities in the United States by race/ethnicity, education, and economic status: findings from two nationally representative surveys.

Authors:  Xinzhi Zhang; Mary Frances Cotch; Asel Ryskulova; Susan A Primo; Parvathy Nair; Chiu-Fang Chou; Linda S Geiss; Lawrence E Barker; Amanda F Elliott; John E Crews; Jinan B Saaddine
Journal:  Am J Ophthalmol       Date:  2012-12       Impact factor: 5.258

9.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

10.  Follow-up compliance after emergency department evaluation.

Authors:  A R Magnusson; J R Hedges; M Vanko; K McCarten; J C Moorhead
Journal:  Ann Emerg Med       Date:  1993-03       Impact factor: 5.721

View more
  2 in total

1.  Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.

Authors:  Jonathan F Russell; Hasenin Al-Khersan; Yingying Shi; Nathan L Scott; John W Hinkle; Kenneth C Fan; Cancan Lyu; William J Feuer; Giovanni Gregori; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2020-03-13       Impact factor: 5.258

2.  Temporal Trends in the Treatment of Proliferative Diabetic Retinopathy: An AAO IRIS® Registry Analysis.

Authors:  Dan Gong; Nathan Hall; Tobias Elze; Lucia Sobrin; Joan W Miller; Alice Lorch; John B Miller
Journal:  Ophthalmol Sci       Date:  2021-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.